CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Voice Assistant Device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05081011
NCT05081011N/ACompleted
CompareCT.gov

Using an AI-based Voice Assistant to Manage Insulin in Diabetes: a Randomized-Control Trial

Stanford University·interventional·Posted Oct 18, 2021·Updated Jan 2, 2024

In Brief

A clinical study evaluating Voice Assistant Device for Medication Adherence. Completed, enrolled 39 participants across 1 site.

Detailed Summary

This study randomizes participants to have their basal insulin titrated either through standard of care or by receiving prompts through interactions with an AI-enabled smart speaker device. The primary objective of this study is to investigate the feasibility of an AI-enabled smart speaker device and whether such a device facilitates insulin titration management, increases insulin adherence and decreases time to optimal insulin dose. The secondary objective of the study is to explore whether the device improves glycemic control as defined by improvements in fasting blood sugar.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMedication Adherence
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 18, 2021
Enrollment StartMar 24, 2021
Primary CompletionDec 1, 2022
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 4.7 years ago

Interventions

Voice Assistant Devicedevice

Voice AI-enabled smart speaker device delivers daily custom insulin titration instructions.

Voice Assistant Devicedevice

Voice AI-enabled smart speaker device delivers daily generic insulin reminders.